| IPO7 |
IPO7: Uncharacterized protein IPO7 |
EIF5AP1 |
EIF5A: Eukaryotic translation initiation factor 5A-1 |
0.36 |
Evidence |
|
| IPO7 |
IPO7: Uncharacterized protein IPO7 |
PPIA |
PPIA, CYPA: Peptidyl-prolyl cis-trans isomerase A |
0.36 |
Evidence |
|
| SFRS15 |
SFRS15, KIAA1172: Splicing factor, arginine/serine-rich 15 |
SFRS5 |
SFRS5, HRS, SRP40: Splicing factor, arginine/serine-rich 5 |
0.36 |
Evidence |
|
| SNCG |
SNCG, BCSG1, PERSYN, PRSN: Gamma-synuclein |
PTK2 |
PTK2, FAK, FAK1: Focal adhesion kinase 1 |
0.36 |
Evidence |
|
| CXorf9 |
IPI00004504 |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
0.36 |
Evidence |
|
| CXorf9 |
IPI00004504 |
OSBPL11 |
OSBPL11, ORP11, OSBP12: Oxysterol-binding protein-related protein 11 |
0.36 |
Evidence |
|
| CXorf9 |
IPI00004504 |
MAP3K8 |
MAP3K8, COT, ESTF: Mitogen-activated protein kinase kinase kinase 8 |
0.36 |
Evidence |
|
| CXorf9 |
IPI00004504 |
NCF1 |
Neutrophil cytosolic factor 1 variant (Fragment) |
0.36 |
Evidence |
|
| EIF3S4 |
EIF3S4: Eukaryotic translation initiation factor 3 subunit 4 |
HNRPA0 |
HNRPA0: Heterogeneous nuclear ribonucleoprotein A0 |
0.36 |
Evidence |
|
| EIF3S4 |
EIF3S4: Eukaryotic translation initiation factor 3 subunit 4 |
MATR3 |
MATR3, KIAA0723: Matrin-3 |
0.36 |
Evidence |
|
| GRAP2 |
GRAP2, GADS, GRB2L, GRID: GRB2-related adapter protein 2 |
SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
0.36 |
Evidence |
|
| GRAP2 |
GRAP2, GADS, GRB2L, GRID: GRB2-related adapter protein 2 |
PASK |
PASK, KIAA0135: PAS domain-containing serine/threonine-protein kinase |
0.36 |
Evidence |
|
| GRAP2 |
GRAP2, GADS, GRB2L, GRID: GRB2-related adapter protein 2 |
ARHGEF6 |
ARHGEF6, COOL2, KIAA0006, PIXA: Rho guanine nucleotide exchange factor 6 |
0.36 |
Evidence |
|
| WDHD1 |
WDHD1, AND1: WD repeat and HMG-box DNA-binding protein 1 |
CENPA |
CENPA: Histone H3-like centromeric protein A |
0.36 |
Evidence |
|
| KIAA0788 |
ASCC3L1, HELIC2, KIAA0788: U5 small nuclear ribonucleoprotein 200 kDa helicase |
EIF4G1 |
EIF4G1, EIF4F, EIF4G, EIF4GI: Eukaryotic translation initiation factor 4 gamma 1 |
0.36 |
Evidence |
|
| SF3B1 |
SF3B1, SAP155: Splicing factor 3B subunit 1 |
H1FX |
H1FX: Histone H1x |
0.36 |
Evidence |
|
| NCOR1 |
NCOR1, KIAA1047: Nuclear receptor corepressor 1 |
TERF2 |
TERF2, TRBF2, TRF2: Telomeric repeat-binding factor 2 |
0.36 |
Evidence |
|
| NCOR1 |
NCOR1, KIAA1047: Nuclear receptor corepressor 1 |
SP100 |
IPI00011675 |
0.36 |
Evidence |
|
| NCOR1 |
NCOR1, KIAA1047: Nuclear receptor corepressor 1 |
UBTF |
UBTF, UBF, UBF1: Nucleolar transcription factor 1 |
0.36 |
Evidence |
|
| ZNF217 |
ZNF217, ZABC1: Zinc finger protein 217 |
ZNF267 |
ZNF267: Zinc finger protein 267 |
0.36 |
Evidence |
|
| ADAM23 |
ADAM23, MDC3: ADAM 23 precursor |
EPHA4 |
EPHA4, HEK8, SEK, TYRO1: Ephrin type-A receptor 4 precursor |
0.36 |
Evidence |
|
| NBN |
NBN, NBS, NBS1, P95: Nibrin |
DYNC1LI1 |
DYNC1LI1, DNCLI1: Cytoplasmic dynein 1 light intermediate chain 1 |
0.36 |
Evidence |
|
| NBN |
NBN, NBS, NBS1, P95: Nibrin |
PIK3CG |
PIK3CG: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma i |
0.36 |
Evidence |
|
| NBN |
NBN, NBS, NBS1, P95: Nibrin |
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
0.36 |
Evidence |
|
| NBN |
NBN, NBS, NBS1, P95: Nibrin |
PCNA |
PCNA: Proliferating cell nuclear antigen |
0.36 |
Evidence |
|